|
Market Cap (17-May) $17,684,784 (923rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 0 |
Shortsold (17-Apr) 8,415 (0.00%) (600th) |
|
52w High $0.064 |
52w Low $0.021 |
P/E - |
EPS 0 |
EMD released this announcement to the ASX on 13 October 2022, 9:43. The announcement is not marked as price sensitive, and is 32 page(s) in length and 5.3MB in size.
You can view all announcements from EMD and see how they appear on a price chart on the announcements page.
At the date of this announcement, EMD was 0.086% short sold according to ASIC data. It was ranked the 470th most shorted stock on the ASX. It remains ranked 600th as of the latest reported data (17 April 2025).
| Other Recent Announcements from EMD | |
|---|---|
| Trading Halt | 29 June 2023, 9:33 |
| Emyria Receives Ethics Approval for MDMA-assisted Therapy | 8 June 2023, 9:10 |
| Section 708A(5)(e) Notice | 10 May 2023, 18:37 |
| MDMA-inspired drug discovery presentation | 13 October 2022, 9:43 |
| Emyria Investor Webinar - October 13 | 10 October 2022, 9:31 |
| Emyria expands clinical sites for EMD-RX5 Phase 3 trial | 26 September 2022, 8:18 |
| Letter to Shareholders - Annual General Meeting | 23 September 2022, 17:45 |
You must be logged in to post a reply.
Emyria 